Tuesday | June 25, 2024

7:00 am Check-In & Refreshments

Workshop A

Artificial Intelligence in Retinal Imaging: Developing Algorithms for Improved Data Analysis & Diagnosis of Retinal Diseases


With the improvement in current imaging technology and the development of novel modalities, artificial intelligence (AI) algorithms have been increasingly explored and implemented. AI algorithms have allowed data analysis to be more streamlined and accurate for improved workflow in clinical trials.

This workshop will:

  • Discuss how AI can be introduced in clinical trials and provide suggested diagnosis for better patient stratification
  • Discovering how to train AI to understand the differences between normal and pathological retina and understand disease prognosis and response to treatment
  • Examine the engineering challenges when developing and training AI algorithms to match the needs of AI image analysis in the clinic
  • Understand how AI will provide precision analysis that improves workflow for faster visualization and quantification of disease activity and therapeutic successes
  • Establish how AI can improve workflow and reduce burden from skilled clinicians and ophthalmologists when labelling data sets

10:00 am Morning Networking Break

Workshop B

Combining Imaging Modalities for Clinical Trial Biomarkers & Management of Retinal Diseases


OCT imaging is the leading diagnostic intervention in all medicine. It produces high resolution, 3D images and is the most available retinal imaging tool. However, with the varying natures of different retinal diseases, different modalities are required to image different retinopathies. This workshop will address how these different imaging modalities can be combined and information can be extracted from a device that might not be possible to capture using another device.

This workshop will:

  • Review current modalities, such as OCT, OCT A, Fluorescein angiography and color fundus photography, to avoid relying on only one system and getting similar results from the different modalities
  • Discuss the advantages and limitations of combining imaging modalities
  • Analyze why it isn’t currently possible to validate data collected from one imaging tool by using a different imaging tool

12:30 pm Lunch & Networking Break

Workshop C

Developing Novel Imaging Regulatory Decision-Enabling Endpoints for Clinical Validation


Most optometric instruments are designed to assess vision to achieve functional endpoints and efficacy. To better understand the structure-function relationship and create more reliable assessments, imaging endpoints are being developed. This workshop will dive into how the criteria for getting approval for imaging endpoints in the clinic.

In this session, you will:

  • Find efficacy on multiple endpoints to increase cooperation and build a link between structure and function
  • Discuss the current criteria for an efficacious endpoint – content validity, construct validity, variability and ability to show change
  • Understand the performance characteristics of retinal imaging biomarkers
  • Examine reduced endpoint variability to establish efficacy in treatment modalities

3:30 pm End of Pre-Conference Workshop Day